These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 872039)

  • 1. Comparative effect of anaerobic coryneforms on a murine melanoma.
    Paslin DA
    Cancer; 1977 Jun; 39(6):2405-10. PubMed ID: 872039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of a hamster melanoma with intralesional Corynebacterium granulosum.
    Paslin D
    Br J Dermatol; 1976 Jun; 94(6):639-44. PubMed ID: 949459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice.
    Barth RF; Singla O
    Cancer Res; 1978 Jan; 38(1):32-4. PubMed ID: 618580
    [No Abstract]   [Full Text] [Related]  

  • 4. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 5. [Corynebacteria--stimulators of antitumor resistance].
    Zatula DG; Zaval'niuk AK; Tofan AV
    Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of nonspecific immunotherapy on the course of murine melanoma.
    Woods JE; Ritts RE
    J Surg Oncol; 1977; 9(1):15-20. PubMed ID: 839793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
    Ullrich RL; Adams LM
    Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimetastatic effect of cell-wall skeleton of Propionibacterium acnes C7 on Lewis lung carcinoma in C57BL/6J mice.
    Tanio Y; Yamamura Y; Saiki I; Okumura H; Kamisango K; Okuyama H; Azuma I
    Gan; 1981 Jun; 72(3):403-10. PubMed ID: 7319198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific and specific active immunotherapy in a B16 murine melanoma system.
    Avent J; Vervaert C; Seigler HF
    J Surg Oncol; 1979; 12(1):87-96. PubMed ID: 480953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aerobic and anaerobic corynebacteria on reaginic antibody response in mice.
    Adachi H; Yabu-Uchi K; Ozawa K; Sindo T; Tadokoro I
    Microbiol Immunol; 1978; 22(1):53-6. PubMed ID: 661628
    [No Abstract]   [Full Text] [Related]  

  • 16. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 17. Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model.
    Knapp RC; Berkowitz RS
    Am J Obstet Gynecol; 1977 Aug; 128(7):782-6. PubMed ID: 560124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages.
    Wilkinson PC; O'Neill GJ; Wapshaw KG
    Immunology; 1973 Jun; 24(6):997-1006. PubMed ID: 4197975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
    Pot-Deprun J; Chouroulinkov I
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.